Company / EPS (Diluted)
BioRestorative Therapies, Inc. EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$1.16
FY2025
5-year range
-$28.56 / -$1.16
FY2021-FY2025
Trend
+53.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) has increased for 3 consecutive years, from $-28.56 in FY2021 to $-1.16 in FY2025.
Based on SEC 10-K filings.
-1.16 in FY2025.
Improved from $-5.11 to $-1.16 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (diluted) increased 53.0% year-over-year.
- Peak eps (diluted) was recorded in FY2020.
- Lowest eps (diluted) in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -47.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.16 | +53.0% |
| FY2024 | -$2.47 | +51.7% |
| FY2023 | -$5.11 | - |
| FY2022 | - | - |
| FY2021 | -$28.56 | -4227.3% |
| FY2020 | -$0.66 | +59.8% |
| FY2019 | -$1.64 | +5.7% |
| FY2018 | -$1.74 | +17.1% |
| FY2017 | -$2.10 | +34.4% |
| FY2016 | -$3.20 | +26.9% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026